Badania rynku turystyki medycznej

Medical Tourism is a growing industry worldwide due to the increase in health treatment costs in home countries, the globalization of the healthcare industry and increasing access to skilled medical workers worldwide. Countries in Emerging Markets are prioritizing this industry to attract medical tourists and boost exports of advanced service industries such as healthcare, biotechnology and pharmaceutical sectors.

Medical Tourism is defined as the process of traveling outside the country of residence to receive medical care. Although many identify medical tourism as people who travel from wealthy countries to developing countries to receive cheaper medical care, the process also applies to the opposite situation in which people from less developed countries travel to rich economies to perform operations not easily provided in their home countries.

SIS analyzes all the potential opportunities that this way of working brings and how potential customers and providers can prosper and enhance treatments.

About the Medical Tourism Market

Medical Tourism is present in almost all countries around the world. For example, US residents travel to Mexico, Canada, or the countries of Central, and South America for cheaper healthcare, while Europeans travel outside the EU or between countries where prices are lower.

Some of the most popular destinations are Cuba, Greece, Thailand, Korea and Serbia because their doctors and specialists are among the best in the world.

The most common reasons why people travel to another country for medical care are:

1. Price (many people travel to other countries because they cannot afford medical insurance on their own or because the procedure costs are way above their budget, so we can conclude that this is the main reason for medical tourism)
2. The legality of service (some health services such as abortion or euthanasia are forbidden by law in some countries, but not in all of them)
   Cultural differences (a lot of immigrants want to be treated in their country of origin, because of their religious beliefs)
3. Access to experimental procedures
4. Access to enhanced quality of care

Among the procedures people decide to go to another country are (but are not limited to): fertility treatments (e.g. surrogacy, IVF, and assisted reproductive technologies), organ transplantations, plastic surgery, dental care, and experimental cancer treatments.

Badania rynku dotyczące podróży klienta can uncover numerous sources of competitive advantage in the Medical Tourism sector. Customers face numerous benefits and risks in medical tourism and the stakes can be high. Before patients decide to have their procedure done in a foreign country, they often conduct comprehensive in-person and online research to pick the right facility, treatment and medical provider for his or her needs. As these decisions can be outside their domestic medical establishments, the online research that patients conduct is important in their decision making. Furthermore, people who opt for medical tourism often exhaust all available medical treatment options in their home country so they can be a vulnerable group requiring information about benefits and risks. Market Research provides the insight for Medical Tourism providers to better serve potential patients.

The most common complications of medical tourism include:

1. Diseases and risk of infections – from procedure complications (wound or donor-derived infections) to infectious diseases if a person travels to faraway countries
2. Resistance to antibiotics – this is a relatively rare risk, but every medical tourist needs to be aware of it
3. Problems with communication – only registered facilities can provide staff with advanced knowledge of the English language or the patient’s native language, which is essential for proper care
4. Air travel – if patients fly right away after the surgery, they are at high risk of blood clots or other travel risks, so it is advisable to wait at least 10-14 days before heading back home

Medical Badania rynku turystycznego: How Leading Operators Build Cross-Border Patient Pipelines

Medical tourism market research has shifted from descriptive country profiling to operational intelligence that informs corridor selection, payer partnerships, and clinical specialty positioning. The sophisticated buyers in this category, hospital networks, sovereign health funds, insurer-employer coalitions, and private equity-backed specialty groups, treat patient flow modeling the way airlines treat route economics.

The global cross-border patient market spans elective orthopedics, oncology second opinions, fertility, dental, cardiac, and bariatric procedures. Each travels along distinct corridors with distinct economics. Mexico-US dental and bariatric flows behave nothing like Gulf-to-Germany oncology referrals or China-to-Japan precision medicine cases. Treating them as a single market produces unusable forecasts.

Why Corridor-Level Medical Tourism Market Research Outperforms Country Reports

Country-level sizing obscures the unit of competition. Patients do not choose Thailand. They choose a specific Bangkok hospital with JCI accreditation, a named surgeon, an English-speaking concierge, and a payer arrangement that covers travel. Corridor analysis isolates origin-destination pairs and decomposes them into procedure mix, payer source, facilitator margin, and length-of-stay economics.

The leading operators model corridors the way logistics firms model lanes. Singapore-Indonesia cardiac. Turkey-UK hair restoration and dental. Costa Rica-US dental and orthopedics. Korea-China aesthetic surgery. India-East Africa oncology. Each corridor has a distinct conversion funnel from inquiry to deposit to arrival to follow-up, and the leakage points differ.

According to SIS International Research, the operators winning share in mature corridors invest heavily in pre-arrival clinical triage, often a structured remote consultation that qualifies the patient and pre-builds the care plan. This single step compresses on-site length of stay, reduces clinical surprises, and lifts deposit-to-arrival conversion materially above facilitator-led alternatives.

The Five Forces Reshaping Cross-Border Patient Flows

Five structural forces govern where the next decade of growth concentrates. Each is measurable and each rewards firms that build proprietary intelligence rather than rely on syndicated reports.

Payer integration. Self-funded US employers, UK NHS overflow contracting, and Gulf state-sponsored programs have moved from pilot to procurement. The buyer is no longer the patient. It is a benefits committee or a sovereign health authority running an RFP with bundled-price expectations and outcomes reporting requirements.

Accreditation as table stakes. JCI, Temos, and ISO 9001 certifications no longer differentiate. The differentiator is publishing risk-adjusted outcomes by surgeon and procedure, the standard set by Bumrungrad, Anadolu Medical Center, and Apollo Hospitals.

Facilitator disintermediation. Hospitals with mature international patient departments, Gleneagles, Asan Medical Center, Hospital Israelita Albert Einstein, are building direct payer relationships and bypassing traditional facilitators on high-margin cases.

Telemedicine pre-screening. Remote second opinions have become the top of the funnel. The hospital that captures the second opinion captures a disproportionate share of conversions.

Visa, currency, and geopolitical friction. Corridor economics shift quickly with visa policy and exchange rates. Turkey’s lira depreciation rebuilt its dental and aesthetic corridors within two years. Sanctions and travel restrictions can collapse a corridor in a quarter.

What Sophisticated Medical Tourism Market Research Actually Measures

Descriptive market sizing is the entry-level deliverable. The intelligence that informs capital allocation goes deeper.

Source: SIS International Research

The patient journey layer is where most market entry decks are weakest. Cross-border patients make decisions across an eight-to-fourteen-week window with multiple household stakeholders, and the conversion-killing moments are rarely clinical. They are visa anxiety, deposit refund policy ambiguity, and post-arrival communication gaps.

The SIS Approach to Medical Tourism Market Research

SIS International’s healthcare practice combines structured B2B expert interviews with international patient department directors, ethnographic research with returning patients, and competitive intelligence on hospital pricing, accreditation, and outcomes disclosure. A recent mixed-methodology engagement targeted 200 respondents across Brazil to map inbound and outbound patient flows for a Fortune 500 healthcare client evaluating Latin American corridor expansion.

The healthcare practice has fielded patient-side and provider-side studies across China, Mexico, the United States, Germany, Korea, Singapore, and Israel, including direct CEO-level interviews with overseas medical services agencies serving outbound Chinese patients. This dual-perspective design, capturing both the originating facilitator and the receiving hospital, surfaces the pricing and commission realities that single-sided studies miss.

SIS Corridor Viability Framework

Four dimensions determine whether a corridor merits investment.

• Volume durability. Is the patient flow tied to a structural cost or capacity gap, or to a temporary currency arbitrage?
• Payer concentration. Are the buyers individuals or institutional payers with renewable contracts?
• Clinical defensibility. Does the destination have outcomes data and surgeon depth that withstand a malpractice-conscious payer audit?
• Operational maturity. Are the international patient department, concierge, billing, and follow-up workflows institutionalized or improvised?

Corridors strong on all four, Singapore cardiac, Korea oncology, Turkey dental and orthopedics, sustain investment through currency cycles. Corridors weak on payer concentration or clinical defensibility tend to be margin-thin and reputation-fragile.

Where the Market Goes Next

Three shifts will define the next phase of corridor competition. First, employer-direct contracting will move from pilot programs at large self-funded US employers into mid-market benefits design, expanding addressable demand for centers of excellence in Mexico, Costa Rica, and Colombia. Second, fertility tourism will continue to outgrow other categories as regulatory arbitrage and donor availability concentrate volume in Spain, Greece, the Czech Republic, and parts of Latin America. Third, oncology second opinions delivered remotely will become the primary acquisition channel for high-acuity cross-border cases.

SIS International’s structured expert interviews with overseas medical services agencies indicate that destination preference among high-net-worth outbound patients is driven less by price and more by perceived clinical reputation, language infrastructure, and the agency’s own relationships with named physicians at receiving hospitals. The implication for hospitals is that physician-level brand investment outperforms institutional marketing in this segment.

Medical tourism market research that informs board-level decisions does not stop at market size. It quantifies corridor durability, payer concentration, clinical defensibility, and operational readiness, and it does so with primary evidence from both ends of the patient journey.

O firmie SIS International

SIS Międzynarodowy oferuje badania ilościowe, jakościowe i strategiczne. Dostarczamy dane, narzędzia, strategie, raporty i spostrzeżenia do podejmowania decyzji. Prowadzimy również wywiady, ankiety, grupy fokusowe i inne metody i podejścia do badań rynku. Skontaktuj się z nami dla Twojego kolejnego projektu badania rynku.